Dr. Gennadiy Grutman, MD

Dr. Grutman practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Grutman's NPI, 1487950762, was assigned on February 2, 2011. Dr. Grutman graduated from St. Matthew's University in 2009. Dr. Grutman holds New York license 266521.

Dr. Grutman's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Grutman's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. The medical group on file is NewYork-Presbyterian Medical Group/Westchester. Dmand AI also links Dr. Grutman to 2 more clinical labs, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Grutman practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Grutman's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Grutman is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Grutman's licenses on file in 2 states: New York and New Jersey.

Dmand AI lists acute diabetes, acute skin infection, anemia, bile duct problems, cellulitis, chest pain, chronic diabetes and chronic hypertension among the conditions Dr. Grutman treats.

CMS data shows 1,485 Medicare services from Dr. Grutman across 7 procedure codes in 2024, for 494 Medicare patients. Medicare paid $131,437 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 494 Medicare patients who saw Dr. Grutman in 2024. The largest group is 75 to 84, with 163 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 55% are also on Medicaid. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Grutman's median patient age at 70, with 57% women.

In 2024, Dr. Grutman wrote 231 Medicare Part D claims for 50 patients. 75% of them were for generic drugs. CMS names the drug for 27 of them, across 2 drugs with 11 or more claims each, at $98 in total drug cost. In 2023, CMS named 77 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Grutman for performance year 2024, reported as part of a group. Dr. Grutman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Grutman, published from 2021 to 2023. Dr. Grutman's most frequent co-authors are Samy I. McFarlane, MD and Parag Mehta, MD.

CMS Open Payments shows 10 general payments to Dr. Grutman from 2 drug and device companies in 2016. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $137.

Dr. Grutman graduated from St. Matthew's University in 2009.

Dr. Grutman is in network with 18 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.